StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
QCLS

Q/C Technologies, Inc.

QCLS Nasdaq In Vitro & In Vivo Diagnostic Substances EDGAR ↗
$2.93
+0.00 0.00%

Key statistics

from XBRL data in SEC filings
Market cap
$23.0M
Revenue (TTM)
$862K
Net income (TTM)
-$11.7M
EPS (TTM)
$-8.49
P/E ratio
Dividend yield
Free cash flow
-$9.13M
Cash
$1.13M
Total assets
$38.3M
Gross margin
-37.2%
52-week range
$2.50 – $12.20

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Terminated a material agreement; Other events Jul 2, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 29, 2026 10-K Fiscal year ended 2025-12-31 Apr 15, 2026 8-K Changed accountants Mar 13, 2026 8-K Entered a material agreement; Director or officer change; Other events Jan 23, 2026 8-K Entered a material agreement; Unregistered sale of equity; Other events Dec 9, 2025 10-Q Quarter ended 2025-09-30 Nov 19, 2025 8-K Director or officer change; Shareholder vote results Nov 14, 2025 8-K/A Director or officer change Oct 6, 2025 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Director or officer change Oct 3, 2025 8-K Amended charter or bylaws; Regulation FD disclosure Sep 26, 2025 8-K Entered a material agreement; Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure Sep 10, 2025 8-K/A Sep 5, 2025 8-K Entered a material agreement; Terminated a material agreement; Unregistered sale of equity; Modified rights of security holders; Director or officer change; Amended charter or bylaws; Regulation FD disclosure Sep 2, 2025 10-Q Quarter ended 2025-06-30 Aug 19, 2025 8-K Modified rights of security holders; Amended charter or bylaws; Shareholder vote results Jun 6, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 8-K Amended charter or bylaws May 9, 2025 8-K Item 5.08 Apr 11, 2025 10-K Fiscal year ended 2024-12-31 Apr 11, 2025 8-K Delisting notice or listing-rule failure Mar 21, 2025 8-K Regulation FD disclosure Mar 10, 2025 8-K Director or officer change; Shareholder vote results Nov 26, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Entered a material agreement; Unregistered sale of equity; Other events Oct 7, 2024 8-K Changed accountants Oct 4, 2024 8-K Item 5.08 Sep 23, 2024 10-Q Quarter ended 2024-06-30 Aug 19, 2024 8-K Entered a material agreement; Modified rights of security holders; Amended charter or bylaws Aug 14, 2024 8-K Modified rights of security holders; Amended charter or bylaws; Shareholder vote results Jul 26, 2024 8-K Amended charter or bylaws; Regulation FD disclosure Jul 26, 2024 8-K Modified rights of security holders; Amended charter or bylaws Jun 24, 2024 8-K/A Entered a material agreement Jun 20, 2024 8-K Entered a material agreement; Modified rights of security holders; Director or officer change; Amended charter or bylaws; Other events Jun 17, 2024 8-K Modified rights of security holders; Amended charter or bylaws; Other events May 23, 2024 8-K Entered a material agreement; Unregistered sale of equity; Modified rights of security holders; Amended charter or bylaws; Other events May 21, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 8-K Director or officer change Apr 18, 2024 8-K Entered a material agreement; Modified rights of security holders; Director or officer change; Amended charter or bylaws Apr 8, 2024